Realizing effectiveness across continents with hydroxyurea(reach): a phase i/II pilot study of hyroxyurea for children with sickle cell anemia

Active Cooperative Agreement Awarded Last action

Award ID
U01HL133883
Recipient
Awarding agency
Obligated
$18,888,351

Award facts

Assistance listing
93.837 Cardiovascular Diseases Research
Completion date 92% complete
Originally
Funding
  • $18,212,531.00 Federal
  • $675,820.00 Non-federal
Place of performance
Cincinnati, OH 45229, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $19,975 $0
Amendment $196,803 $0
Amendment $282,506 $0
Amendment $244,008 $0
Amendment $178,823 $0
Amendment $344,224 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $19,975 $0
Amendment $178,823 $0
Amendment $244,008 $0
Amendment $178,823 $0
Amendment $244,008 $0
Amendment $19,975 $0
Amendment $196,803 $0
Amendment $196,803 $0
Amendment $282,506 $0
Amendment $282,506 $0
Amendment $500,339 $0
Amendment $500,339 $0
Amendment $1,423,588 $0
Amendment $1,150 $0
Amendment -$1,150 $0
Amendment $1,150 $0
Amendment -$1,150 $0
Amendment $1,431,382 $0
Amendment $1,431,382 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $1,545,130 $0
Amendment $1,545,130 $0
Amendment $1,545,130 $0
Amendment $675,820 $0
Amendment $675,820 $0
Amendment $675,820 $675,820
Amendment $676,152 $0
Amendment $676,152 $0
Amendment $0 $0
Amendment $685,789 $0
Amendment $11,985 $0
Original award $757,780 $0
Show all 50

Subawards

Subrecipient Amount Awarded
University Health Network Realizing Effectiveness Across Continents with Hydroxyurea(REACH): A Phase I/II Pilot Study of Hyroxyurea for Children with Sickle Cell Anemia $19,975
Mbale Clinical Research Institute LIMITED Realizing Effectiveness Across Continents with Hydroxyurea REACH A Phase I/II Pilot Study of Hydroxyurea for children with Sickle Cell Anemia $282,506
University Of Oxford Realizing Effectiveness Across Continents with Hydroxyurea (REACH): A Phase i/II Pilot Study of Hydroxyurea for Children with Sickle Cell Anemia $244,008
Centre Hospitalier Mère Et Enfant Monkole Realizing Effectiveness Across Continents with Hydroxyurea (REACH): A Phase I/ll Pilot Study of Hydroxyurea for Children with Sickle Cell Anemia $178,823
Subrecipient not on record Realizing Effectiveness Across Continents with Hydroxyurea (REACH): A Phase I/II Pilot Study of Hydroxyurea for Children with Sickle Cell Anemia $196,803
University Of Oxford Realizing Effectiveness Across Continents with Hydroxyurea(REACH): A Phase I/II Pilot Study of Hyroxyurea for Children with Sickle Cell Anemia $132,584
University Health Network Realizing Effectiveness Across Continents with Hydroxyurea(REACH): A Phase I/II Pilot Study of Hyroxyurea (REACH) $19,975
Subrecipient not on record Realizing Effectiveness Across Continents with Hydroxyurea(REACH): A Phase I/II Pilot Study of Hyroxyurea (REACH $139,438
Mbale Clinical Research Institute LIMITED Realizing Effectiveness Across Continents with-Hydroxyurea(REACH): A Phase 1/11 Pilot Study of Hyroxyurea (REACH) $137,790
Centre Hospitalier Mère Et Enfant Monkole Realizing Effectiveness Across Continents with Hydroxyurea(REACH): A Phase I/II Pilot Study of Hyroxyurea (REACH $68,837
University Health Network Realizing Effectiveness Across Continents with Hydroxyurea(REACH): A Phase I/II Pilot Study of Hyroxyurea for Children with Sickle Cell Anemia $19,975
University Of Oxford $78,966
Mbale Clinical Research Institute LIMITED Realizing Effectiveness Across Continents with Hydroxyurea (REACH) $137,789
The Feinstein Institutes For Medical Research Realizing Effectiveness Across Continents with Hydroxyurea (REACH): A Phase I/II Pilot Study of Hydroxyurea for Children with Sickle Cell Anemia $87,464
Baylor College Of Medicine Realizing Effectiveness Across Continents with Hydroxyurea(REACH): A Phase I/II Pilot Study of Hyroxyurea (REACH $59,105
Show all 15

Quick answers

Who received award U01HL133883?

U01HL133883 was awarded to Childrens Hospital Medical Center by National Heart Lung and Blood Institute (National Institutes of Health) on August 1, 2017.

How much is award U01HL133883 worth?

$18,888,351 has been obligated on U01HL133883: $18,212,531 in federal funding and $675,820 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award